Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy

Bibliographic Details
Main Authors:	Raphael Reinhard, MD, Christoffer Gebhardt, MD, Nolwenn Maurier, MD, Lionel Larribère, PhD, Azadeh Orouji, MD, Jochen Utikal, MD
Format:	Article
Language:	English
Published:	Elsevier 2018-03-01
Series:	JAAD Case Reports
Subjects:	BRAF MEK melanoma metastases targeted therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512617302138

id	doaj-38eafea9e81a4d83a0e6c6b6ed753d77
record_format	Article
spelling	doaj-38eafea9e81a4d83a0e6c6b6ed753d772020-11-24T21:53:33ZengElsevierJAAD Case Reports2352-51262018-03-014212913110.1016/j.jdcr.2017.09.007Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapyRaphael Reinhard, MD0Christoffer Gebhardt, MD1Nolwenn Maurier, MD2Lionel Larribère, PhD3Azadeh Orouji, MD4Jochen Utikal, MD5Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDepartment of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDepartment of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDepartment of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDepartment of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyDepartment of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germanyhttp://www.sciencedirect.com/science/article/pii/S2352512617302138BRAFMEKmelanomametastasestargeted therapy
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Raphael Reinhard, MD Christoffer Gebhardt, MD Nolwenn Maurier, MD Lionel Larribère, PhD Azadeh Orouji, MD Jochen Utikal, MD
spellingShingle	Raphael Reinhard, MD Christoffer Gebhardt, MD Nolwenn Maurier, MD Lionel Larribère, PhD Azadeh Orouji, MD Jochen Utikal, MD Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy JAAD Case Reports BRAF MEK melanoma metastases targeted therapy
author_facet	Raphael Reinhard, MD Christoffer Gebhardt, MD Nolwenn Maurier, MD Lionel Larribère, PhD Azadeh Orouji, MD Jochen Utikal, MD
author_sort	Raphael Reinhard, MD
title	Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy
title_short	Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy
title_full	Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy
title_fullStr	Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy
title_full_unstemmed	Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy
title_sort	multiple epidermotropic melanoma metastases developing during braf and mek inhibitor therapy
publisher	Elsevier
series	JAAD Case Reports
issn	2352-5126
publishDate	2018-03-01
topic	BRAF MEK melanoma metastases targeted therapy
url	http://www.sciencedirect.com/science/article/pii/S2352512617302138
work_keys_str_mv	AT raphaelreinhardmd multipleepidermotropicmelanomametastasesdevelopingduringbrafandmekinhibitortherapy AT christoffergebhardtmd multipleepidermotropicmelanomametastasesdevelopingduringbrafandmekinhibitortherapy AT nolwennmauriermd multipleepidermotropicmelanomametastasesdevelopingduringbrafandmekinhibitortherapy AT lionellarriberephd multipleepidermotropicmelanomametastasesdevelopingduringbrafandmekinhibitortherapy AT azadehoroujimd multipleepidermotropicmelanomametastasesdevelopingduringbrafandmekinhibitortherapy AT jochenutikalmd multipleepidermotropicmelanomametastasesdevelopingduringbrafandmekinhibitortherapy
_version_	1725871354428784640

Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy

Similar Items